DOUGLAS GESSL

Profile

First Name

: DOUGLAS

Middle Name

:

Last Name

: GESSL

Related Companies

Titles

Company Name

Related People

EXECUTIVE OFFICER

CEPTARIS THERAPEUTICS, INC

KAMIL ALI-JACKSON, ROBERT J. ALONSO, ALBERT CHA, EVAN DICK, JOHN DOUX, DAVID DRAHAMS, DAVID C. DRAHMS, DOUG GESSL, WILLIAM HAMILTON, WILLIAM F. HAMILTON, TIMOTHY HENKEL, THOMAS P. HESS, JAMES HUANG, STEPHEN TULLMAN, GREG VONTZ, H. JEFFREY WILKINS, JEFF WILKINS

EXECUTIVE OFFICER

ALEXAR THERAPEUTICS, INC.

KAMIL ALI-JACKSON, JASON HONG, RAJU MOHAN, DAVID PFEIFFER, SOMASUNDARAM SUBRAMANIAM, SOMU SUBRAMANIAM, STEPHEN TULLMAN, NEAL WALKER

EXECUTIVE OFFICER

VELICEPT THERAPEUTICS, INC.

JAMES BENNETHUM, CORY S. FREEDLAND, CORY FREEDMAN, DOUG GESSL, DAVID HIRSCH, DAVID HIRSCH, M.D., AIDAN KING, AIDAN KING, MBA, CFA, JILL BECKER MAST, SCOTT MORENSTEIN, STEPHEN TULLMAN, JAMES WALKER, JAMES C. WALKER

EXECUTIVE OFFICER

RALEXAR THERAPEUTICS, INC.

KAMIL ALI-JACKSON, JASON HONG, RAJU MOHAN, DAVID PFEIFFER, SOMASUNDARAM SUBRAMANIAM, SOMU SUBRAMANIAM, STEPHEN TULLMAN, NEAL WALKER

EXECUTIVE OFFICER

ONSPIRA THERAPEUTICS, INC.

PAUL BARONE, ROY LEVITT, BRIAN LORTIE, STEPHEN TULLMAN

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Debt

2017-06-16

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2018-12-20

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Debt

2017-06-16

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2018-07-12

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Debt

2017-06-16

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2017-05-31

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2015-11-23

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2015-11-23

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2014-01-03

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2014-01-03

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2012-05-14